Lumexa Imaging Holdings (LMRI) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.26
- Estimate
- $0.21
- Surprise
- +26.7%
- Score today
- 5.1/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Lumexa Imaging Holdings (LMRI) beat the $0.21 estimate with adjusted EPS of $0.26 — a large 26.7% upside surprise.
Coverage in the report window
- Lumexa Imaging Holdings, Inc. Reports Third Quarter 2026 Financial Results — fiscal.ai, 2026-11-10
- Lumexa Imaging Holdings Raises FY2026 Adj EPS Guidance from $0.71-$0.77 to $0.86-$0.90 vs $0.77 Est; Affirms FY2026 Sale — benzinga, 2026-11-10
- Lumexa Imaging Holdings Q3 Adj. EPS $0.26 Beats $0.18 Estimate, Sales $271.973M Beat $269.894M Estimate — benzinga, 2026-11-10
Where TrendMatrix's rating stands now
TrendMatrix currently rates LMRI Sell at 5.1/10; no pre/post engine snapshot brackets this report.
1 of the last 2 quarters beat the estimate; this quarter's +26.7% surprise compares with a -25.5% four-quarter average. Next scheduled report: 2027-03-25.
What argues against it
- Concentration risk — Product: advanced imaging (MRI/CT/PET) (52.0%)
- Target reached (-3.6% upside)
- Quality below floor (2.2 < 4.0)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $15.95
- Stop
- $14.83
Risk check: RSI 89 — a level conventionally read as overbought; gains at these levels often lean on momentum; trading volume is running 2.3× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-12 — shown for context, not personalized investment advice.
LMRI at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $1.53B
- P/E (fwd)
- 17.2
- 52-week range
- $6.45–$19.45
- Off 52-week high
- 18.0%
- RSI (14)
- 89
- Volume vs avg
- 2.25×
- Score today
- 5.1/10